Identity
- Trade Name
- Bioventus Clinician Kit FDA UDI
- Generic Name
- Spinal cord/peripheral nerve implantable analgesic electrical stimulation system programmer FDA UDI
- Model / Reference
- PNS-1000 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00816986020624 FDA UDI
- FDA Product Code
- GZF FDA UDI
- GMDN Term
- Spinal cord/peripheral nerve implantable analgesic electrical stimulation system programmer FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 882.5870 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
MR Unsafe FDA UDI
Category: Spinal cord/peripheral nerve implantable analgesic electrical stimulation system programmer
Bioventus Clinician Kit by Bioventus Llc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Spinal cord/peripheral nerve implantable analgesic electrical stimulation system programmer.
- Omnia — Nevro Corporation · Class III
- Omnia — Nevro Corporation · Class III
- ReActiv8 Programming Wand — MAINSTAY MEDICAL LIMITED · Class III
- BIOTRONIK — BIOTRONIK SE & Co. KG · Class III
- Altius Programmer Wand — Neuros Medical, Inc. · Class III
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Bioventus Llc
Sources (1)
- FDA UDI 8ce35305-497f-475b-8440-6d3d9a903fad 33 fields · synced May 29, 2026